Moving towards a Patent Pool? XVII International AIDS Conference Satellite Forum, MSF, KEI, OXFAM (Mexico, 5 August 2008) Jorge Bermudez Executive-Secretary,

Slides:



Advertisements
Similar presentations
Trade and Health National Assessment The World Health Organisations Diagnostic Tool on Trade and Health Presented by: Corinna Hawkes, Consultant
Advertisements

Mandate and Terms of Reference of the CEWG. The Presentation Background Mandate from the Resolution Points requiring clarity Resolution WHA63.28.
Consultative expert working group - proposals Barcelona
Summary of 3 rd CEWG meeting by Chair and Vice-Chair Open Session CEWG on R&D Financing and Coordination November 18, 2011.
THE INTERNATIONAL DRUG PURCHASE FACILITY-UNITAID Michel D. Kazatchkine, Ministère des Affaires Etrangères, France.
Fostering R&D and Promoting Access to Medicines (for all) From Alma Ata, via Doha to Geneva (in 10 minutes) Bellagio, Italy October 2007 Ellen ‘t.
Prize for TB low-cost point of care rapid diagnostic test Pierre Chirac Médecins Sans Frontières, Paris, France Campaign for Access to Essential Medicines.
Overview of the Global Fund: Guiding Principles Grant Cycle / Processes & Role of Public Private Partnerships Johannesburg, South Africa Tatjana Peterson,
Patent Pools Increasing access to Medicines and Innovation Ellen ‘t Hoen MSF Access to Essential Medicines Campaign Barcelona 9 Dec
Intellectual Property Rights Regulations in Russia: Case of Government-Supported R&D Irina Dezhina Leading Researcher, Ph.D. Institute for the Economy.
National symposium on Competition law: Evolution and Transition, 2012 Competition Policy for IP Issues Pradeep S Mehta Secretary General, CUTS International.
Action for Global Health, Sala Capranichetta, Piazza Montecitorio, 125, Rome, 9 th February |1 | by David B Evans, Director Department of Health.
Public health, innovation and intellectual property 1 |1 | WHO/UNICEF Technical Briefing Seminar on Essential Medicines Policies Global Strategy and Plan.
Affordability of HIV/AIDS treatment in developing countries: modeling ARV drug price determinants for a better understanding of the market functioning.
IGWG process Gaudenz Silberschmidt, Switzerland Public Health, Innovation and Intellectual Property Global strategy and Plan of Action Dr Gaudenz Silberschmidt,
Access to Innovation: Making Generic Versions of Newer Antiretrovirals Affordable Focusing on middle income countries Leena Menghaney, MSF Access Camapign.
WIPO’s Strategies on Intellectual Property and Economic Development WIPO’s Strategies on Intellectual Property and Economic Development United Nations.
A very short introduction to patents & access to medicines.
UNITAID An innovative mechanism for scaling up access to medicines and diagnostics for HIV/AIDS, tuberculosis and malaria Jorge Bermudez, Executive Secretary,
Australia’s Innovation Action Plan – Self-Assessment Report June 2010 Barry Jones Industry and Small Business Policy Division.
National Medicine Policy
UNITAID’s Market Approach in HIV Diagnostics Brenda Waning International AIDS Society 18 July, 2011 Rome.
Atlanta meeting Getting it done for maternal and new born health PwC: A partner in development 20 January
UNITAID The HIV/AIDS Medicines Patent Pool Initiative October 2010.
Using the levy in order to finance recurring expenditures : the case of the International Drug Purchase Facility-UNITAID Meeting of experts on the solidarity.
Trade-related policies and access to medicines ICTSD Consultation on trade policy coherence and access to medicines Geneva November 7 th 2006,
The Draft SADC Annex on Trade in Services UNCTAD Secretariat Sub-regional Conference on Improving Industrial Performance and Promoting Employment in SADC.
WHO Perspective on Medicine Patents and FTAs Asian Regional Workshop on FTAs August, 2005, Kuala Lumpur, Malaysia Dr Zafar Mirza Regional Adviser,
EU Climate Action EU – Central Asia Working Group on
The Medicines Patent Pool Ellen ‘t Hoen UNITAID Consultative Forum Geneva, 4-5 October 2011.
Sustainable Approaches to Opening Access to Medical Inventions James Love Wizards of OS Berlin 15 Sept 06.
UNITAID Matching Innovation and Sustainability: An Innovative Mechanism for Scaling-up Treatment for HIV/AIDS, TB and Malaria Jorge Bermudez, Executive.
“Implementing Spectrum Trading” the recent consultation Presentation to SMAG Open Forum December 2002 Geoff Chapman Radiocommunications Agency.
PATENT POOL & its CONCERNS PATENT POOL & its CONCERNS Manmohan A Amonkar 20 July 2010.
Philippe Duneton11 February 2009 Deputy Executive Secretary 5th Consultative Stakeholder Meeting UN Prequalification of Diagnostics, Medicines & Vaccines.
Donors, prize funds and patent pools. KEI & UNU- MERIT Maastricht Workshop on Medical Innovation Prizes January 28th-29th 2008 Michelle Childs, Head of.
Alexandra Heumber Médecins Sans Frontières Access to Essential Medicines Campaign DEBRIEFING WHA May 2006.
Preliminary classification of proposals by the CEWG Proposals for innovative financing: Discussing the work to-date of WHO’S Consultative Expert Working.
Selection of essential medicines Richard Laing and Deidre Dimancesco TBS 2011 Department of Essential Medicines & Pharmaceutical Policies TBS 2008.
ATIS Intellectual Property Rights Policy Review Thomas Goode General Counsel, ATIS DOCUMENT #:GSC13-IPR-08 FOR:Presentation or Information SOURCE:ATIS.
South Africa’s Acceptance of the Protocol Amending the TRIPS Agreement Xolelwa Mlumbi- Peter DDG: ITED 24 November 2015.
The Role of Patents, Universities, and Non-Profits in the Promotion of Health Care Access Nina Gandhi.
Public health, innovation and intellectual property 1 |1 | The Global Strategy on Public Health, Innovation and Intellectual Property Technical Briefing.
Page 0 UNITAID’s Strategic Approach to HIV Diagnostics  Washington DC 22 July, 2012 XIX International AIDS Conference Brenda Waning.
GLOBAL COOPERATION FOR IP AND DEVELOPMENT Esteban Burrone Head of Policy Medicines Patent Pool.
IMPROVING ACCESS AND INNOVATION IN HIV THROUGH VOLUNTARY LICENSING: THE EXPERIENCE OF THE MEDICINES PATENT POOL ICASA – Harare, Zimbabwe Session on Innovation.
Access to medicines challenges in Europe: What is wrong and the way forward Presented by: Rohit Malpani Director of Policy & Analysis, Access Campaign.
UNITAID actions and main achievements Investing in the quality of medicines XVII International AIDS Conference Satellite Forum WHO – Essential Medicines.
PATENT POOL Anand Grover United Nations Special Rapporteur on Health East Africa Consultation, September 2010.
UNGGIM – PRIVATE SECTOR NETWORK. AGENDA > OVERVIEW OF PRIVATE SECTOR >PURPOSE AND VISION OF PRIVATE SECTOR NETWORK > STRUCTURE AND TERMS OF REFERENCE.
World summit on the information society 1 WSIS: Building the Information Society: a global challenge in the new Millennium Tim Kelly, Claudia Sarrocco.
VOLUNTARY PATENT POOLING FOR PUBLIC HEALTH A Model For Innovation And Access.
EDM Strategy for Working with Countries: the Uganda Example
Vietnam Development Partnership Forum
Consultation on the Finance Sector Supplement to the Natural Capital Protocol This project has been made possible by generous funding and support from.
Overview of GEOSS Data Sharing Principles and Implementation GEO-XIII Plenary Side Event Towards Open Earth Observation Data Policies Wenbo Chu GEO.
(UNSD introduction followed by open discussion)
WHO Meeting of Interested Parties
Access to Medicines for HIV/AIDS, Tuberculosis and Malaria.
Amy Marasco, Incoming Vice Chair, ANSI IPRPC
Richard Laing EMP/WHO TBS 2012
Trade-related policies and access to medicines
EU health institutional and policy developments
MACROECONOMICS AND HEALTH
Operations Management Introduction to operations Management 1.
Richard Laing WHO/PAU TBS 2013
Jørgen Friis, ETSI VP SES
Summary of 3rd CEWG meeting by Chair and Vice-Chair
UHC2030 Private Sector Constituency –
Project leader: Richard Morton Lead Editor: Jalal Benhayoun
Presentation transcript:

Moving towards a Patent Pool? XVII International AIDS Conference Satellite Forum, MSF, KEI, OXFAM (Mexico, 5 August 2008) Jorge Bermudez Executive-Secretary, UNITAID

Access to medicines and IPR: a recent issue in the Health Agenda within WHO 1999 (WHA52.19): The revised drug strategy (WHA54.11): WHO medicines strategy (WHA55.14): Ensuring accesibility of essential medicines (WHA56.27): Intellectual property rights, innovation and public health (WHA57.14): Scaling up treatment and care within a coordinated and comprehensive response to HIV/AIDS (WHA59.24): Public health, innovation, essential health research and intellectual property rights: towards a global strategy and plan of action (WHA60.30): Public health, innovation and intellectual property (WHA61.21): Global strategy and plan of action on public health, innovation and intellectual property.

Public Health and IPR: looking forward to reach a balance Innovation (NCE), incremental innovation The neglected and most-neglected diseases Prices of new medicines and diffusion in the relevant markets Public Health and access to medicines Is a balance possible? A continuous process: trade and health, the UK CIPR, WHO CIPIH, IGWG

 MSF paper on medicines patent pool (request to UNITAID and the French Government) - June 2006  IPDS preliminary legal review - July 2007  EB6 - Resolution on patent pool - December 2007  1 st meeting of Expert Group - March 2008  2 nd meeting of Expert Group - June 2008  EB8 approves the principle of the patent pool – July 2008 Background for the UNITAID move

Patent pool (for medicines) A portfolio of assets consisting of the entire set of patents & related information held by various actors (companies, universities, government institutions) related to a particular technology that are made available on a non-exclusive basis to manufacturers and distributors of medicines. Basic concept

Reduce transaction costs Unblock development of technology through a distributed holding of patents Achieve price reduction Encourage competition Objectives of a Patent Pool

A licensing agency to act as an intermediary Set up as a voluntary mechanism Include a wide range of industry players Key features of the Patent Pool

SARS patent pool Public Intellectual Property Resource for Agriculture (PIPRA) licensing arrangement Golden Rice Patent Pool Open Invention Network (OIN) for Linux Software Other examples of patent pools

Geographic coverage: to include all low and middle income countries and allow for exceptions Scope: to focus initially on Pediatric ARVs and new combinations Relationship with UNITAID: a licensing agency legally separated from UNITAID and with full liability Quality assurance : licensing agreements include requirements aimed at ensuring that licensees can meet appropriate quality standards. Recommendations for the setting-up

Increase access to more appropriate and affordable medicines Development of new formulations (new FDCs) Increase competition in the supply of medicines Flexibility in licensing Access to patented technology under reasonable terms Lower prices A win-win proposal? Potential Benefits

UNITAID Board Resolution: the principle of establishing a patent pool (EB8). The Secretariat prepares a budget to set up the process, looking towards a licensing agency (July 2008). Task Force operational (August 2008) Triggering the process and elaboration of draft documents, including license agreements UNITAID discusses and approves the establishment of the Pool (January 2009)? Next steps potentially ahead

(…) Today patent pools are a favoured system in technology sectors that require common standards, such as the MPEG-2, DVD-video, DVD-ROM and radio. Medicines, though, are trickier terrain. (…) UNITAID may be able to pull it off with some luck and lots of hard work. (…) They have a delicate and onerous task before them. Millions of people are waiting hopefully at the patent poolside." Latha Jishnu/ New Delhi July 23, 2008 "From airline tickets to patent pools…

NAL/DATASTATISTICS/0,,menuPK: ~pagePK: ~piPK: ~the SitePK:239419,00.html

UNITAID is hosted and administered by the World Health Organization For more information on UNITAID funded projects please go to: